Newswise — BOSTON – (October 7, 2014) – Lori Laffel, M.D., M.P.H., Chief of Joslin’s clinical programs for Children, Adolescents and Young Adults, and Senior Investigator in the Section on Genetics and Epidemiology, has been promoted by Harvard Medical School to Professor of Pediatrics.
Since 1987 Dr. Laffel has helped in the care of thousands of patients with diabetes. Under her leadership, the pediatric program at Joslin has more than quadrupled in size and is recognized worldwide as a major pediatric diabetes center for clinical care and research. She is the Co-Principal Investigator and Program Director for the NIH-funded Joslin and Boston Children’s Hospital Early Career Development training grant for pediatric endocrinologists entering the field of diabetes research. Dr. Laffel has also been very active on the national policy level. She is a member of the National Committee for Professional Practice Guidelines for the American Diabetes Association (ADA), inaugural Chair of the ADA’s Working Group on Transitions in Care for Young Adults with Diabetes, and past Chair of ADA’s Youth Strategies Committee. She has also been a member of the Advisory Board of the International Society of Pediatric and Adolescent Diabetes (ISPAD) and a member on the Clinical Advisory Committee for the JDRF.
In 2013 she was the Co-editor on the ADA-JDRF Sourcebook on Type 1 Diabetes through the Lifespan, and this year a co-author of the new “ADA Position Statement on Type 1 Diabetes through the Lifespan.”
Dr. Laffel lectures at undergraduate and graduate levels, and serves as mentor for doctoral students, fellows, and junior faculty. She is an invited speaker at local, national, and international meetings, in areas of pediatric diabetes, childhood obesity, behavioral and outcomes research, and the assessment and translation of new technologies in diabetes. She is Principal Investigator on multiple clinical research projects, with grants from NIH, foundations, and industry.
She also participates in the peer-review process for journals and funding organizations locally, nationally, and internationally, reviewing for NIH, JDRF, the French Inserm, the German Research Foundation, Health Research Council of New Zealand, Diabetes UK, and the Dutch Diabetes Research Foundation, among others. She is also an Associate Editor for “Diabetic Medicine.”
Dr. Laffel received her medical degree from the University of Miami School of Medicine, and her master’s degree in Public Health from the Harvard School of Public Health. She completed her pediatric training at Boston Children’s Hospital and her fellowship training at Boston Children’s Hospital and the Joslin Diabetes Center.
About Joslin Diabetes Center
Joslin Diabetes Center, based in Boston, Massachusetts, undertakes diabetes research, clinical care, education and health and wellness programs on a global scale. Joslin is dedicated to ensuring that people with diabetes live long, healthy lives and offers real progress in preventing and curing diabetes. Joslin is an independent, nonprofit institution affiliated with Harvard Medical School, and is recognized worldwide for driving innovative solutions in diabetes prevention, research, education, and care.
Our mission is to prevent, treat and cure diabetes. Our vision is a world free of diabetes and its complications. For more information, visit www.joslin.org.
###
RSS